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Summary 
Individuals suffering from Down syndrome have widespread body frame abnormalities and 
impaired brain development and function; the latter leading to impaired intellectual disability. It 
is caused by having a partial or complete third copy of chromosome 21, and there exists 3 forms: 
simple trisomy 21, translocation trisomy and mosaic trisomy. Symptoms include intellectual 
disabilities/mental retardation, early onset Alzheimer’s disease and the appearance of various 
phenotypic features, such as narrow slanted eyes, flat nose and short stature. In addition, cardiac 
heart defects are very frequent and have significant impact on life expectancy. The most 
common being from the group of endocardial cushion defects, with forms of common AV canal 
being the typical and major presentation. Left untreated, it can be complicated with pulmonary 
hypertension causing symptoms such as tachydyspnea, cyanosis and failure to thrive. There are 
also other health problems throughout the body, like thyroid function abnormalities along with 
nutritional disorders
13
. As the many issues listed above that are vital to health and well-being of 
individuals with DS remain to be studied, this an important and exciting time for chromosome 21 
trisomy research. 
Today all children with congenital heart defect are treated, including those accompanying Down 
syndrome. Together with the changing attitude towards children with trisomy 21, there are many 
issues to be concerned using a multi-systemic approach (medical, educational, environmental), to 
deal with other organic diseases and also cognitive development, to allow DS patients to extract 
their maximum potential and increase their chances of living a rich, independent community life. 
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1. Introduction   
Down syndrome is the most common and the most understood chromosomal abnormality in 
humans occurring at a rate of 1:600-700 newborns. This chromosomal abnormality is primarily 
caused by over-expression of chromosome 21, where instead of two there are three copies
13, 18, 21
 and is 
frequently associated with a varied combination of morphological and structural birth defects. 
These defects include congenital mental disability, hypotonia, characteristic body features, heart 
defects, and other systemic congenital malformations. However, not all defects occur in each 
patient; there is a wide range of phenotypic variations. The impact on each patient is individual, 
with some individuals being severely affected while others are healthy and able to function as 
independent adults
9
. 
It was first described by an English physician John Langdon Down in 1862, who recognized and 
differentiate this syndrome from mental disability. When karyotype techniques were first 
discovered in the mid twentieth century, this led to the understanding that three copies of 
chromosome 21 was the cause of Down syndrome, a finding that was reported by Jerome 
Lejeune, from Paris in 1959. 
 
1.1 Genetic background 
In a normal cell there are 23 pairs of chromosomes, giving a total of 46 chromosomes. Twenty-
two of these are called autosomes, which look the same in males and females, where the last pair 
(23th) is the sex chromosome that indicates the gender, as illustrated in figure 1.  
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Figure 1  The human chromosomes 
 
In Down syndrome patients this is a bit different, they usually have an additional chromosome 21 
making it 3 copies, also known as simple trisomy 21; this extra chromosome affects almost every 
organ system and results in a wide spectrum, of phenotypic consequences. About 95 percent of 
affected persons have simple trisomy 21, so that their chromosome count adds up to 47, which is 
the most common cause of the trisomy, called meiotic nondisjunction. Parents of such children 
have a normal karyotype and are normal in all respect, this incidence is increasing from 1 in 
1,250 at age 25, to 1 in 1,000 at age 30, to 1 in 400 at age 35, to 1 in 100 at age 40, to 1 in 30 at 
age over 45 years
2
, therefore suggesting that in most cases the meiotic nondisjunction of 
chromosome 21 occurs in the ovum, during the formation of reproductive cells (oocytes and 
spermatocytes) and depends on abnormal chromosome separation at the first or second meiotic 
division leading to a double chromosome 21 in these cells
13
. When the chromosome is shown to 
be driven from a paternal chromosome it hasn’t shown any effect of paternal age to this type of 
mutation
15
. In about 4 percent of all patients with DS, the extra chromosomal material is present 
not as an extra chromosome but as a translocation (the transfer of a chromosome fragment to 
another) of long arm of chromosome 21 to, most commonly chromosome 22 or 14. Such cases 
are frequently familial; the translocated chromosome is inherited from one of the parents, who 
are most frequently a carrier of a robertsonian translocation.  In the remainder 1 percent of Down 
syndrome patients are mosaic, when the extra chromosome 21 is present in some, but not all 
cells, of the individual giving a mixture of 46- and 47- chromosome cells. They result from 
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mitotic nondisjunction of chromosome 21 during early stage of embryogenesis; symptoms in 
such cases are variable and milder depending on the proportion of abnormal cells to normal 
cells
15
. Three sub-divisions of mosaic trisomy are found; single cell-type (composed of normal 
and trisomic cells), tissue mosaic trisomy (tissues affected by the chromosome 21 trisomy) and 
chimerism (where two fertilized eggs are fused together into a whole giving rise to a single 
organism; where either or both eggs are affected by mosaicism)
23
. 
Chromosome 21, whether in a Down syndrome individual or not, encodes over 350 genes. 
Individuals who are trisomic have elevated transcript levels of the more than 350 genes on the 
chromosome are primarily responsible, it is likely that multiple genetic mechanisms underlie the 
numerous ways in which development and function diverge in individuals with trisomy 21 
compared to euploid individuals
20
. 
 
1.2 Morphological features 
Each DS child possesses a unique set of phenotypic traits, as will be discussed in the section 
about genetics, however most children have similar morphological features. On physical 
examination, DS patients have characteristic craniofacial findings (demonstrated in figures 2 a-
c), such as: flat occiput and flattened facial appearance, brachycehaly, epicanthal folds, flat nasal 
bridge, upward-slanting palpebral features, Brushfield spots, small nose and mouth, protruding 
tongue, small and dysplastic ears, generous nuchal skin, diastasis recti, single transverse palmar 
crease, short fifth finger with clinodactyly, wide space between the first and second toes (see 
table 1 for detailed information). In addition to these features, DS individuals may exhibit 
shortened extremities, short broad hands, with short fifth middle phalanx and single transverse 
palmar crease (in about 60% of patients), joint hyperextensibility or hyperflexibility, 
neuromuscular hypotonia, dry skin, premature aging, wide range of intelligences quotients (IQs) 
and congenital heart defect. 
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Figure 2b.   Photograph of a girl with                                               
Down syndrome [note: slanted palpebral 
fissures, flat nasal bridge] 
                    
Figure 2c. Photograph of a boy with                                               
Down syndrome [note: small dysplastic ears and 
protruding tongue] 
 
    
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
Figure 2a.     Sketch of craniofacial findings in  
                                                             Down syndrome. 
 
 
 
 
 
 
     
 
 
 
 
 
         
 
5 
 
 
        Table 1.  Dysmorphic features in Down syndrome according 
                                                to sadowska et al.
21
 
 
 
1.3 CNS and psychosomatic manifestations 
The brain of a child with DS develops differently from a normal one, attaining a form of reduced 
in size and altered in configuration. Accumulating evidence shows that DS is characterized by 
numerous neurodevelopmental alterations among which reduction of neurogenesis, dendritic 
hypotrophy and connectivity alterations appear to play a particularly prominent role.
10
 Hypotonia 
seen in the newborn period is followed by developmental delay and mental retardation. In 
addition, all individuals with DS demonstrate the neuropathology of Alzheimer disease by age 
30–40 years. The unavoidable hallmark of DS, intellectual disability, has heavy impact on 
families and society. The IQ score usually falls in the moderately to severely retarded range (IQ= 
25-55) and mental age is rarely over 8 years. The IQ in DS is not constant during life but 
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decreases with age and an early deceleration occurs between the age of 6 months and 2 years, 
with future decline in adolescents. Children with DS exhibit incomplete and delayed acquisition 
of motor, linguistic, cognitive and adaptive functions, compared with developing children of the 
same mental age
22
. 
In terms of behavior and psychiatric status, DS individuals have natural spontaneity, genuine 
warmth, cheerfulness, gentleness, patience, and tolerance. At least half of all children and adults 
with Down syndrome face a major mental health concern during their life span. The most 
common mental health concerns include: general anxiety, repetitive and obsessive- compulsive 
behavior; oppositional, impulsive and inattentive behaviors, such as attention-deficit hyperactive 
disorder; sleep related difficulties; depression’ autism spectrum conditions; and 
neuropsychological problems characterized by progressive loss of cognitive skills. The pattern of 
mental health problems in these individuals vary depending on the age and developmental 
characteristics of the child or adult with Down syndrome. 
 
1.4 Gastrointestinal abnormalities  
Children and adults with DS will experience gastrointestinal (GI) symptoms from time to time 
such as vomiting,  diarrhea, constipation, abdominal pain and discomfort that resolves with 
minimal or no intervention much as in others. However, they may develop structural and 
functional disorders of the GI tract and related structures more commonly. Structural problems 
may affect the gastrointestinal tract from the mouth to the anus but many conditions will occur in 
Down syndrome with similar frequency to other children. In saying that, esophageal, duodenal, 
and small bowel atresia or stenosis, annular pancreas causing small bowel obstruction, 
imperforated anus and Hirschsprung disease (affecting about 2% of those with Down syndrome) 
are more common than in the general population
4
, these may need to be surgically corrected at 
once in order to have a normal functioning intestinal tract. In addition, gastro-esophageal reflux 
should be suspected in a child who appears uncomfortable during or after feeding. Down 
children are prone to this because they spend less time in sitting position and muscle tone in the 
lower esophageal sphincter may be reduced thus allowing reflux.  
7 
 
Adults with DS are also prone to a wide range of gastrointestinal problems including reflux, 
obesity, constipation and diarrhea. Celiac disease which has been noted with prevalence of 5% in 
Down syndrome can present at any age. Symptoms in children and adults are protean and include 
growth failure, malaise, vomiting, abdominal distention, diarrhea and constipation. Unexplained 
anemia, iron and calcium deficiency, point to the diagnosis. Because of the strong association 
some have advocated screening all subjects using human tissue transglutaminase and or 
endomysial antibodies and if CD is diagnosed gluten free diet should be offered with a referral to 
a dietician
11
. 
 
1.5 Endocrine abnormalities  
When it comes to hormone-producing organs and Down’s syndrome it has been noted over the 
past 30 years with many publications have suggested an association between DS and thyroid 
gland disorders by showing altered levels of abnormal thyroxin (T4), triiodothyronine (T3) and/ 
or thyroid stimulating hormone (TSH) levels. An evaluation of reported studies would suggest a 
life-time prevalence of approximately 25-30%. The prevalence of hypothyroidism, the lack of 
thyroid hormone, has been found to be greater than that of hyperthyroidism, at a ratio of 9% to 
2% was proposed
11
; as well as an increase in the prevalence of hormonal abnormalities there is 
also an increased prevalence of autoimmune thyroiditis. As mentioned above, hypothyroidism is 
the commonest form of thyroid disorder associated with Down syndrome. It may be either 
congenital (present at birth) or be acquired (occurring at any age after birth) most commonly in 
teens and early adulthood. Recognition of thyroid disorders (especially hypothyroidism), can be 
difficult; the person with DS is usually shorter in height, appears less active, has dry skin and 
fine hair, excess weight, bradycardia and mental impairment. These features are seen in 
hypothyroidism and therefore, make the early clinical diagnosis of hypothyroidism in individuals 
with Down syndrome difficult.  So, it is recommended by specialists that all infants with Down 
syndrome be checked at birth, six months of age, one year of age, and once a year for thyroid 
function. Treatment consists of replacing thyroid hormones with synthetic ones such as thyroxin 
and treatment is usually needed for life. 
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1.6 Hematopoietic disorders 
Up to 80%, 66%, and 34% of Down syndrome newborns have neutrophilia, thrombocytopenia, 
and polycythemia, respectively. These findings are usually referred collectively as hematological 
abnormalities in the newborn DS (HANDS). In general, hematological abnormalities is HANDS 
are mild, with a benign clinical course, that spontaneously resolves by 2 weeks of age. 
Neutrophilia is mild (rarely exceeding 30,000/µL) and is not associated with infection. 
Thrombocytopenia is mild (majority with platelets counts <150,000/µL) and not associated with 
bleeding. Polycythemia is mild in most cases with only some exhibiting duskiness and cyanosis 
that correct with reduction/partial exchange transfusion. 
Transient myeloproliferative Disorder (TMD) is a disease entity unique to DS newborns and is 
defined as the morphological detection of blasts in DS less than three months of age, occurs at a 
rate of 10% of all patients with Down syndrome. TMD is usually detected in the first week of 
life and spontaneously resolves by 3 months of age
6
.  It is associated with neonatal death 
secondary to liver failure, heart failure, sepsis, hemorrhage, hyperviscosity, and disseminated 
intravascular coagulation in 11 to 52%. After resolution of TMD, approximately 13 to 29% 
develop acute megakaryocytic leukemia (AMKL) after 6 months of age. In addition Down 
syndrome is associated with a 10 to 20 times higher incidence of both acute lymphoid leukemia 
occurring throughout childhood, mainly greater than 4 years of age; and acute myeloid leukemia 
occurring between 6 months to 5 years. 
 
1.7 Additional findings 
Moreover, there are many health problems associated with Down syndrome. Sixty to eighty 
percent of children with DS have hearing deficits and should be seen by an otolaryngologist to 
determine the severity of hearing loss. During childhood problems with sight might become 
visible, for example, 3 percent of those patient have cataracts that need to be removed surgically. 
Other ocular conditions such as cross-eye, near-sightedness, far-sightedness are also frequently 
encountered. Conditions that would need special attention are skeletal abnormalities, including 
patients with kneecap subluxation, hip dislocation and atlanto-axial instability; the latter 
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condition occurs when C1 and C2 bones of the cervical vertebra are not well aligned because of 
the presence of loose ligaments. Most of these patients however, do not have any symptoms, 
except for the one to two percent that require surgical correction. 
 
2.  Congenital heart defects (CHD) 
Children with Down syndrome have about a 40 to 50% incidence of being born with a structural 
problem of the heart. The defects can involve the walls of the heart, the valves of the heart, and 
the veins and arteries coming in and out of the heart, respectively. The blood flow can slow 
down, go in the wrong direction or to the wrong place, or be blocked completely. Therefore, 
CHD contribute significantly to the morbidity and mortality of children with Down's syndrome, 
who as a consequence may develop congestive heart failure, pulmonary vascular disease, 
pneumonia, or failure to thrive.  
In most of the European countries, Sudan, Turkey and the USA, atrioventricular septal defect 
(AVSD) is the most common cardiac defect with an incidence of 48%, second to that is 
ventricular septal defect (VSD) at rate of 35%, secundum atrial septal defect (ASD) with 8% 
occurrence and patent ductus arteriosus (PDA) at a rate of 7%
9
.  
 
 
2.1      Normal heart anatomy 
A human heart, being it a child’s heart or adult heart, is a muscular organ about the size of a 
closed fist that functions as the body’s circulatory pump. It is made up of 4 chambers, two atria 
and two ventricles (as demonstrated in figure 3 below). De-oxygenated blood returns to the right 
side of the heart via the venous circulation. It is pumped into the right ventricle and then to the 
lungs where carbon dioxide is released and oxygen is absorbed. The oxygenated blood then 
flows back to the left side of the heart into the left atria, then into the left ventricle from where it 
is pumped into the aorta and arterial circulation to provide the body with oxygen. The pressure 
created in the arteries by the contraction of the left ventricle is the systolic blood pressure. Once 
the left ventricle has fully contracted it begins to relax and refill with blood from the left atria. 
The pressure in the arteries falls whilst the ventricle refills. This is the diastolic blood pressure. 
10 
 
The atrioventricular septum completely separates the two sides of the heart (as shown in figure 2 
below). Unless there is a septal defect the two sides of the heart never directly communicate. 
Blood flows from right side to the left side of the heart via the lungs only. However the chambers 
themselves work together. The two atria contact simultaneously (during diastolic phase), and the 
two ventricles contract simultaneously (during systolic phase). The atria are separated from the 
ventricles by atrioventricular valves, allowing blood to flow in one direction that is, from the 
atria to the ventricles. The AV valve on the right side is called the tricuspid valve because it is 
made of three cusps that allows blood to pass through and prevent regurgitation. Similarly on the 
left side the AV valve is called the bicuspid valve because it has two cusps. 
 
 
Figure 3.  Anatomical heart sketch, coronal plane. 
[R: right; L: left; RA: right atria; LA: left atria; RV: right ventricle; LV: left ventricle; A: aorta;  
PA: pulmonary artery; SVC: superior vena cava; TV: tricuspid valve; MV: mitral valve] 
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2.2     Atrioventricular septal defect 
Atrioventricular septal defect is the most common heart defect, present in 48% of all DS patients. 
It refers to a broad spectrum of malformations characterized by a deficiency of the 
atrioventricular septum and abnormalities of the atrioventricular valves. These malformations are 
presumed to result from failure of fusion of the endocardial cushions in the central portion of the 
heart, causing a lesion that involves the atrial and ventricular septum, as well as the anterior 
mitral and septal tricuspid valve leaflets (as shown in figure 4 below). In complete AV canal 
defect there is a combined deficiency of the atrial and ventricular septum associated with a 
common AV orifice rather than separate tricuspid and mitral valves. When this common AV 
valve opens predominantly towards one ventricle or the other, an unbalanced AV canal forms. If 
the atrioventricular valve predominantly opens into the morphological left ventricle, the defect is 
termed a left ventricular type (or LV-dominant AV septal defect). If the common AV valve 
opens predominantly into the morphological right ventricle, the defect is termed a right 
ventricular type (or RV-dominant AV septal defect). The degree of unbalance varies from mildly 
unbalanced with 2 nearly normal sized ventricles and therefore termed balanced atrioventricular 
septal defect, to severely unbalanced leaving one of the ventricles hypoplastic, even rudimentary, 
and its associated outflow tract with essentially single- ventricle physiology. RV-dominant AV 
septal defects occur more commonly than the LV-dominant AV septal defects. 
Complete AV canal defects produce severe pathophysiological changes, because the large 
intracardiac communication and significant AV valve regurgitation contribute to ventricular 
volume loading and pulmonary hypertension. Children with AV canal defect develop signs of 
chronic heart failure (CHF) within the first few months of life. On physical examination there 
may be a right ventricular heave and a systolic murmur. Chest radiography will be consistent 
with CHF, and the electrocardiogram (ECG) will demonstrate right ventricular hypertrophy with 
prolonged PR interval. A two-dimensional echocardiography with color-flow mapping is 
confirmatory, but cardiac cauterization should be performed to define the status of the pulmonary 
vasculature, with a pulmonary vascular resistance (PVR) greater than eight Woods units 
indicates inoperability. 
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Figure 4.  Atrioventricular septal defect sketch, coronal plane. 
[R: right; L: left; RA: right atria; LA: left atria; RV: right ventricle; LV: left ventricle; A: aorta;  
PA: pulmonary artery; SVC: superior vena cava] 
 
The management of patients with AV canal defects can be especially challenging. They should 
be operated by the first year of life to prevent irreversible changes in the pulmonary circulation. 
The defect is repaired by patch closure of the VSD, separating the common AV valve into 
tricuspid and mitral components and suspending the neovalves from the top of the VSD patch, 
and closing the ASD. With unbalanced defect, the operation should be carried out in philosophy 
of single ventricle, which means, first by banding of the pulmonary artery, then Glenn and finally 
total cavopulmonary connection (mostly extracardiac Fontan operation). It is not uncommon to 
have additional problems with AV canal defect, depending on whether it is left or right ventricle 
obstruction that might significantly influence hemodynamics. For example, a common AV canal 
with pulmonary stenosis (so called tetralogy of Fallot); also there are types that have subaortic or 
other left ventricle obstructive defects. Those with decreased pulmonary artery flow (in terms of 
TOF type) can benefit from aortopulmonary anastomosis (B-T shunt). Those with unobstructed 
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blood flow to the lungs, suffering from pulmonary overflow und pulmonary hypertension can 
benefit from pulmonary artery banding.  
Pulmonary artery banding (PAB) is a technique of palliative surgical therapy used by congenital 
heart surgeons as a staged approach to operative correction of congenital heart defects, it is a 
surgical intervention for infants born with cardiac defects characterized by left-to-right shunting 
and pulmonary over circulation. Although the use of pulmonary artery banding has recently 
significantly decreased, it continues to maintain a therapeutic role in certain subsets of patients 
with congenital heart disease. The primary objective of performing pulmonary artery banding is 
to reduce excessive pulmonary blood flow and protect the pulmonary vasculature from 
hypertrophy and irreversible (fixed) pulmonary hypertension. This is done by putting a band on 
the main pulmonary artery, making an artificial stenosis that lowers the pulmonary flow and so 
prevent pulmonary hypertension. 
 The prognosis of patients with complete AVSD is poor with mortality rate of 3 to 13%. The 
most common encountered postoperative complications are complete heart block (1 to 2%). 
Right bundle branch block (22%), arrhythmias (11%), right ventricular obstructive tract (11%) 
and severe mitral valve regurgitation (13 to 24%).  
 
2.3     Ventricular septal defect 
Ventricular septal defect refers to a hole between the left ventricle and the right ventricle, as 
shown in figure 5 below. These defects occur in 35% of Down syndrome patients. VSDs vary in 
size from 3 to 4mm to more than 3cm, and are classified into four types based on their location in 
the ventricular septum: perimembraneous, AV canal (so called – inlet VSD), outlet or 
supracristal, and muscular. 
Large VSDs allow free flow of blood from the left ventricle to the right ventricle, elevating the 
right ventricular pressures to the same level as systemic pressures. Consequently, the pulmonary-
to-systemic flow ratio is inversely dependent on the ratio of PVR to systemic vascular resistance 
(SVR). Large VSD produce a large increase in pulmonary blood flow, and the afflicted infant 
will present with symptoms of CHF; left untreated, these defects will cause pulmonary 
14 
 
hypertension with a corresponding increase in pulmonary vascular resistance. This will lead to a 
reversal of flow (a right-to-left shunt), which is known as Eisenmenger’s syndrome; for that 
pulmonary banding procedure is an excellent option as early palliative surgical therapy to 
prevent pulmonary hypertension and consequently Eisenmenger’s syndrome. In contrasts to 
small VSDs which offer significant resistance to the passage of blood across the defect, and 
therefore, right ventricular pressure is either normal or only minimally elevated, making these 
defects generally asymptomatic because of few physiological consequences. However, a long-
term risk of endocarditis, because endocardial damage from the jet of blood through the defect 
may serve as a possible nidus for colonization. 
 
 
Figure 5.   Ventricular septal defect sketch, coronal view. 
[R: right; L: left; RA: right atria; LA: left atria; RV: right ventricle; LV: left ventricle; A: aorta;  
PA: pulmonary artery; SVC: superior vena cava] 
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As mentioned above, large VSDs will present with severe CHF and frequent respiratory tract 
infections. Those with Eisenmenger’s syndrome may be deceptively asymptomatic until frank 
cyanosis develops. The chest radiography will show cardiomegaly and pulmonary over-
circulation and the ECG will show signs of left ventricular or biventricular hypertrophy. 
Echocardiography provides definitive diagnosis, and can estimate the degree of shunting as well 
as pulmonary arterial pressures. 
VSDs may close or narrow spontaneously, and the probability of closure is inversely related to 
the age at which the defect is observed. Thus, infants at 1 month of age have 80% incidence of 
spontaneous closure, whereas a child at 12 months of age has only a 25% chance of closure
3
. 
This has important impact on operative decision making, because a small or moderate-size VSD 
may be observe for a period of time in the absence of symptoms. Large defects and those in 
severely symptomatic neonates should be repaired during infancy to relieve the symptoms and 
because irreversible changes in pulmonary vascular resistance may develop during the first year 
of life. The used technique to repair a VSD is a patch repair. Even in very small infants, closure 
of VSD can be safely preformed with hospital mortality near 0%.  
 
2.4     Atrial septal defect  
Atrial septal defect (ASD) is defined as an opening in the inter-atrial septum that enables the 
mixing of blood from the systemic venous and pulmonary venous circulations, as shown in 
figure 6 below. In Down’s syndrome this heart defect is seen in 8% of individuals. ASDs result 
in an increase in pulmonary blood flow secondary to left-to-right shunting through the defect. 
The direction of the intracardiac shunt is predominantly determined by the compliance of the 
respective ventricles. In utero, the distensibility of the right and left ventricles is equal, but 
postnatally the LV becomes less compliant than the RV. This shift occurs because the resistance 
of the downstream vascular beds changes after birth. The pulmonary vascular resistance (PVR) 
falls with the infants’ first breath, decreasing RV pressure, whereas the systemic vascular 
resistance rises dramatically, increasing the LV pressure. This increase in pressure creates a 
thicker muscle mass which offers a greater resistance to diastolic filling than does the RV; thus, 
the majority of flow through ASD occurs from left to right. The greater the volume of blood 
16 
 
returning to the right atrium causes volume overload in the RV, but because of its lower muscle 
mass and low-resistance output, it easily distends to accommodate this load.  
The long-term consequence of RV volume overload includes hypertrophy with elevated RV end-
diastolic pressure and a relative pulmonary stenosis across the pulmonary valve, because it can’t 
accommodate the increase RV flow. This resistance at the level of the pulmonary valve then 
contributes further pressure load on the RV, which accelerates the RV hypertrophy. The ability 
of RV to recover normal function is related to the duration of chronic overload, because 
undergoing ASD closure before age 10 years have a better likelihood of achieving normal RV 
function in the postoperative period
16
. 
 
Figure 6.  Atrial septal defect sketch, coronal plane. 
[R: right; L: left; RA: right atria; LA: left atria; RV: right ventricle; LV: left ventricle; A: aorta;  
PA: pulmonary artery; SVC: superior vena cava] 
 
Patient with ASD are usually asymptomatic with few physical findings. Auscultation may reveal 
prominence of the first heart sound with fixed splitting of the second heart sound; resulting from 
the relatively fixed left-to-right shunt throughout all phases of the cardiac cycle. Chest 
radiographs in a patient with ASD may show evidence of increase pulmonary vascularity, with 
17 
 
prominent hilar markings and cardiomegaly. The electrocardiogram shows right axis deviation 
with an incomplete bundle-branch block. Diagnosis is clarified with echocardiogram and the use 
of color flow mapping facilitated the understanding of the physiologic derangements created by 
the defect. 
In general, ASDs close when patients reach 4 to 5 years of age; if that doesn’t happen then 
surgery is an option, either by primary repair or by insertion of a patch that is sutured to the rim 
of the defect or by device closure. Mortality rate of surgically repaired ASD is near zero percent. 
Early repairs in neonates weighing less than 1000 grams have been increasingly reported to with 
excellent results
19
. 
Besides ostium secundum atrial septal defect, another DS characteristic is ostium primum ASD 
is located in the most anterior and inferior aspect of the atrial septum just above the valves and is 
the simplest form of AV septal defect. Children with smaller ostium primum ASD and little or 
no mitral regurgitation or left ventricle to right atrium shunting are usually asymptomatic. Those 
with significant pulmonary over circulation and/or significant mitral regurgitation tend to present 
in infancy with congestive heart failure. Tachypnea and tachycardia are noted at rest and are 
exacerbated with crying or exertion. Feeding is accompanied by dyspnea, diaphoresis, and an 
increased work of breathing. The combination of feeding difficulties and increased metabolic 
demands results in failure to thrive, which may be severe and/or intractable. 
The cardiac examination in isolated ostium primum ASDs or partial AV canal defects with 
minimal mitral regurgitation is similar to that in other forms of ASDs. Patients typically have an 
increased right ventricular impulse secondary to volume overload. The first heart sound is 
normal. The second heart sound is fixed or at least widely split. A systolic ejection murmur is 
heard loudest at the upper left sternal border, with radiation to both lung fields. A click is not 
present. A tricuspid mid-diastolic rumble is present in children with larger shunts (pulmonary-to-
systemic flow ratio > 2:1) and is appreciated at the lower left sternal border. 
Unlike ostium secundum ASD, the ostium primum ASD is not amenable to device closure in the 
cardiac catheterization laboratory. The device is unable to be adequately seated secondary to an 
inadequate inferior rim of atrial septal tissue and the proximity of the defect to the AV valves.  
Therefore, definitive management of hemodynamically significant ASD is operative surgery, it is 
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done electively between ages 2 and 5 years. Occasionally, repair (done through a right atrial 
incision) may be recommended at an earlier age because of significant congestive heart failure or 
failure to thrive, especially if associated with significant mitral valve regurgitation.  
 
2.5    Persistent patent ductus arteriosus  
The ductus arteriosus is derived from the sixth aortic arch and normally extends from the main or 
left pulmonary artery (PA) to the upper descending thoracic aorta, distal to the left subclavian 
artery. It is the least common structural defect to occur in DS at a rate of only 7%. In normal fetal 
cardiovascular system, ductal flow is considerable (about 60% of the combined ventricular 
output), and is directly exclusively from the PA to the aorta
17
. During the fetal period the ductus 
blood flow is maximally maintained by locally produced and circulating prostaglandin E2 (PGE2) 
and PGI2; they cause relaxation of the ductal musculature. At birth, the increase in pulmonary 
blood flow metabolizes these prostaglandin products, and absence of the placenta removes an 
important source of them, resulting in a marked decrease in these ductal-relaxing substances. In 
addition, release of histamines, catecholamines, bradykinin, and acetylcholine all promote ductal 
contraction. Despite all of these actions, the rise in oxygen tension in the fetal blood is the main 
stimulus causing smooth muscle contraction and ductal closure within 24 to 48 hours postnatally. 
Anatomical closure by fibrosis produces the ligamentum arteriosus connecting the PA to the 
aorta (as demonstrated in figure 7).  
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Figure 7.   Patent ductus arteriosus, sketch. 
[Yellow arrows indicate the direction of blood flow, A: aorta; PA: pulmonary artery] 
 
 
PDA is not a benign entity, although prolonged survival has been reported. Estimated death rate 
for infants with isolated untreated PDA is approximately 30%
5
. The leading cause of death is 
CHF, with respiratory infection as a secondary cause. After birth, in an otherwise normal 
cardiovascular system, a PDA results in a left-to-right shunt that depends on both the size of the 
ductal lumen and its total length. As the pulmonary vascular resistance falls 16 to 18 weeks 
postnatal, the shunt will increase, and its flow will ultimately be determined by the relative 
resistances of pulmonary and systemic circulations. 
The hemodynamic consequences of the ductal shunt are left ventricular overload with increased 
LA and PA pressures, and right ventricular strain from the augmented afterload. These changes 
cause hormonal disturbances in the body by increasing the sympathetic discharge, tachycardia, 
tachypnea, and ventricular hypertrophy. The diastolic shunt results in lower aortic diastolic 
pressure and increase the potential for myocardial ischemia and under perfusion of other 
systemic organs, while the increase pulmonary flow leads to increased work of breathing and 
decreased gas exchange. 
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Physical examination of the afflicted infant will reveal evidence of a hyperdynamic circulation 
with a widened pulse pressure and a hyperactive precordium. Auscultation demonstrates a 
systolic or continuous murmur, most commonly known as machinery murmur. Cyanosis is not 
present in uncomplicated isolated PDA. Chest radiography may reveal increase pulmonary 
vascularity or cardiomegaly, and the ECG may show LV strain, LA enlargement, and possibly 
RV hypertrophy. 
The presence of persistent PDA is sufficient indication for closure because of the high mortality 
and risk of endocarditis. In older patients who already show signs of pulmonary hypertension, 
closure may not improve symptoms and is associated with much higher mortality. In premature 
infants, aggressive intervention with indomethacin or ibuprofen to achieve early closure of the 
PDA is beneficial unless contraindications such as necrotizing enterocolitis or renal 
insufficiency
12
. Term infants, however, are generally unresponsive to pharmacological treatment 
and therefore, unfortunately need to undergo mechanical closure once the diagnosis has been 
established. This is accomplished either surgically or with a catheter-based therapy. In premature 
infants the surgical mortality is very low, although hospital death due to other complications is 
reportedly high. In older infants and children, mortality is less than 1%.  
Other heart defects that can be found in Down syndrome patients is Tetralogy of Fallot, which is 
classically understood to involve four anatomical abnormalities of the heart (a pulmonary 
infundibular stenosis- mostly caused by overgrowth of the heart muscle; over-riding aorta- an 
aortic valve with biventricular connection, situated above the VSD and connected to both the 
right and left ventricle; VSD and a right ventricular hypertrophy- which increases further due to 
the right ventricular outflow tract obstruction). It is the most common cyanotic heart defect and 
the most common cause of blue baby syndrome. TOF is usually right-to-left shunt, in which 
higher resistance to right ventricle outflow results in more severe cyanosis symptoms. TOF is 
surgically treated by Blalock-Thomas-Taussig shunt. Patients who have undergone total surgical 
repair of tetralogy of Fallot have improved hemodynamics and often have good to excellent 
cardiac function after the operation with some to no exercise intolerance (New York Heart 
Association Class I-II).  
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3.    Antenatal screening for Down’s and its importance 
Over the past 20 years, new technology has improved the methods of detection of fetal 
abnormalities, including Down syndrome. The first prenatal diagnosis of DS was made in 1968, 
and screening woman on the basis of advanced maternal age with amniocentesis was gradually 
introduced into the medical practice all around the world. Low maternal serum alpha-fetoprotein 
levels were associated with Down syndrome in 1983. Later, elevated human chorionic 
gonadotropin and low unconjugated estriol levels were found to be markers for Down syndrome. 
By 1988, use of the three biochemical markers together with maternal age, had been accepted as 
a method of prenatal screening for DS in the general population. Currently in the general 
population, maternal age, ultrasound findings, and maternal serum markers (in the first or second 
trimester) are used alone or in combination for risk calculations
8
. 
 
3.1     Ultrasonography 
With prenatal ultrasonography, trisomy 21 may be diagnosed in the second and third trimester of 
pregnancy. Suggestive prenatal ultrasound findings may be followed with amniocentesis and 
fetal chromosome analysis. Antenatal ultrasonography may reveal the following: 
 Soft markers seen in the second trimester for Down syndrome include the absence or 
hypoplastic nasal bone (observed in 43-62% of trisomy 21 fetuses, compare with 0.5-
1.2% of normal fetuses), thickened nuchal fold, echogenic bowel (seen in 15% of the 
trisomic fetuses in comparison to 0.6% of normal fetuses), shortened long bones (are 
associated with an increased risk of chromosomal abnormalities), and pyelectasis (in 
17%).  
 Other ultrasonographic abnormalities include cystic hygroma, duodenal atresia or 
stenosis (double-bubble sign), cardiac defects (endocardial cushion defect with ASD and 
VSD defects, abnormal mitral and tricuspid valves). 
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Even with these changes found while preforming and ultrasonographic examination, they should 
not be relied on as the primary method of diagnosing Down syndrome since these features could 
be part of other chromosomal abnormalities, other syndromes or even present as isolated 
anomalies. The diagnosis can even be missed in affected families. 
 
3.2      Maternal serum biochemical markers 
Early during pregnancy, all women are offered screening of several blood markers that can 
indicate increased fetal risk for certain genetic diseases and birth defects. Between 15 and 21 
weeks’ of gestation, a maternal serum sample is screened for alpha-fetoprotein (AFP), estriol and 
human chorionic gonadotropin (hCG). 
A decreased level of AFP was associated with Down syndrome. AFP level combined with 
maternal age, along with additional markers found in maternal serum (estriol and hCG), provide 
a sensitive serum screening test. Low levels of maternal serum AFP and estriol, along with high 
levels of hCG suggest an increased risk of Down syndrome. Inclusion of a fourth marker, 
inhibin-A, in the maternal serum screen further improves the accuracy in predicting risk of DS
1
. 
The baby’s risk is then calculated based upon the levels of the three (or four) markers measured 
plus additional factors such as woman’s age, weight, multiple pregnancies, race and whether she 
had diabetes requiring insulin treatment. Since this is a screening test, abnormal test result only 
indicates an increased risk and does not diagnose a birth defect or genetic disease. Additional 
tests would need to be performed to give a definitive diagnosis. 
 
3.3     Invasive diagnostic tests 
Invasive procedures are performed on fetus or embryo before it is born. The aim is to detect 
chromosomal abnormalities, genetic diseases and other conditions, to enable timely medical or 
surgical treatment of a condition before or after birth, to give parents the option of abortion (not 
by suggesting abortion but by informing them about the possible consequences that are expected 
with DS newborns and giving them a way “out”), to give parents the chance to “prepare” 
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psychologically, socially, financially, and medically for a baby with a health problem or 
disability, or for the likelihood of stillbirth. Invasive method involves a probe or needles being 
inserted into the uterus, the following procedures are options to be done to give a definitive 
diagnosis of Down syndrome: 
 Amniocentesis, routinely preformed at 14-16 weeks’ gestation, remains the criterion 
standard. Testing for chromosomal disorders is 99.5% accurate; rarely results can be 
inaccurate if maternal-cell contamination occurs. The associated risk of fetal loss is very 
small, 1:200-300. 
 Chorionic villus sampling is performed at 10-13 weeks’ gestation; earlier testing is 
thought to be associated with a 0.5-1% risk of fetal loss after the procedure. The accuracy 
of chorionic villus sampling (96-98%) is less than that of mid-trimester amniocentesis, 
because of confined placental mosaicism and maternal-cell contamination.  
 Percutaneous umbilical blood sampling is approximately 95% successful in obtaining 
blood sample for cytogenic testing. The fetal loss rate is 3.25%. 
 
 
4. Down syndrome’s impact on society 
Surprisingly the main finding of research studies (from Western or European cultures, in the US, 
Australia and the UK) is normality, the majority of families with children with Down syndrome 
lead ordinary lives. This does not mean that families do not have additional demands and 
challenges to cope with. It means that at least 65-70% of families find the resources to meet the 
additional needs of their child or adult with Down syndrome and lead happy and ordinary family 
lives themselves
7
. They have reported less stress in the family than families with similar levels of 
intellectual disability of different cause; there may be several reasons for this, such as early 
diagnosis and support, information which helps parents to predict the future, the sociable and 
warm nature of most children and adults with Down syndrome and few behavioral problems than 
in other comparison groups. 
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The other 30-35% of families show signs of considerable stress or distress, for variety of reasons. 
Brothers, sisters and the child with DS are more likely to show behavioral difficulties like with 
any other family who has a disabled child. 
Social network of a family with a Down’s child could have a very strong positive source of 
support, provided that they are positive about the child with Down syndrome and welcome them 
into their homes or activities. The beliefs that people have about disability and Down syndrome 
will influence their attitudes and this will apply to family member, friends and contacts in shops 
and public transport. More often you will notice that parents educate those around them, 
including some service providers, that’s why it is really important to raise awareness about DS. 
Many families report the benefit of joining parent support groups for Down syndrome 
associations and meeting other families with children with DS. It has been reported that the most 
significant emotional and practical help that they received came from other parents. 
In summary the discernible differences concerning the medical condition and the developmental 
level between Down syndrome children are caused, among other things, by the different medical 
treatments and the support of each child's environment. Multi-systemic support (medical, 
educational, environmental) can bring many improvements in the children's function, allowing 
them to extract their maximum potential and increases their chances to live a rich, independent 
community life. 
 
5. Advances and future prospects in Down’s syndrome 
By now it is clear that an additional copy or partial copy of chromosome 21 is the cause of Down 
syndrome. It is proposed that this trisomy results in the increased expression of many of the 
genes encoded on this chromosome. The imbalance in expression of chromosome 21 genes and 
the non-chromosome 21 genes is hypothesized to result in many phenotypes that characterize 
DS. Thus to understand this syndrome, it is crucial both to understand the genomic content of 
chromosome 21 and to evaluate how the expression levels of these genes are altered by the 
presence of the third copy of this chromosome using mice models with the same chromosomal 
abnormality that causes down syndrome. 
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Recent interest in therapy for people with DS has focused on pharmacological treatment to 
enhance cognition. A number of compounds have been shown to improve learning in mouse 
models with trisomy 21. These compounds reduce gamma-aminobutyric acid-mediated 
inhibition in the hippocampus and are proposed to improve cognition by releasing normal 
learning from excess inhibition. 
These recent breakthroughs in understanding this trisomy has illustrated that research efforts in 
this field are making significant strides to understand and to develop treatments for the 
debilitating aspects of the syndrome.  
Therefore, understanding the syndrome goes beyond just knowing its etiology and epidemiology, 
scientists are trying to prevent the many life threatening complications that could arise from the 
primary disabilities and defects that are associated with and are the direct consequence of the 
additional copy of chromosome 21 by testing different hypotheses concerning the underlying 
genetic and molecular basis of this trisomy and so, to improve quality of life as well as life 
expectancy in those individuals 
 
6.     Conclusion 
Down syndrome is a condition in which there is excess genetic material. This genetic addition, 
which is in fact an excess chromosome 21 (all or part of it, in all or part of the body cells), causes 
physical and cognitive delays connected with the syndrome. Down syndrome is the most 
prevalent genetic disorder of all, and its prevalence is the same worldwide, across all races and 
sexes.  
Patients have typical physical and mental characteristics, but only seldom all of them or even 
most of them are found in one single person. If we study the character of children with the 
syndrome, we will find they have a pleasant and convenient temperament and a special character. 
They are friendly, sensitive and have a sharp and developed emotional intelligence. These traits 
assist them in fitting in as a part of society and the community rather successfully. 
Forty to fifty percent of Down syndrome patients are born with a structurally defective heart, 
(ASD, VSD, AV canal defect, PDA and TOF), ranging from simple asymptomatic heart defects 
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to complex life threatening defects that have to be managed during the first year of life to prevent 
irreversible consequences, such as pulmonary hypertension and congestive heart failure. Heart 
transplantation is reserved as last resort for those who surgery is not pliable and for those with 
congestive heart failure. 
Fifty years after the discovery of the origin of Trisomy 21, people with this disorder continue to 
suffer the consequences of an extra copy of the chromosome. Compromised well-being and the 
presence of cardiac disorders and other health problems, including cognitive dysfunction, place 
these people outside of the mainstream, even in highly advanced cultures. However, recent 
advances are showing that it may be possible soon to decipher the underlying genetic and 
molecular bases for their disability and for creating effective treatments. Continued and 
increasing investments in research on the genetic and molecular basis of Trisomy 21 promise to 
transform the lives of these individuals and the communities in which they live; but until that 
goal is reached, we should consider and increase awareness of DS by prenatal screening, 
educating, and recognizing the inevitable disabling intellectual disability and life threatening 
conditions like cardiac defects, which when left untreated is the major cause of death by 1 year 
of age in those patients.  
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